The riboflavin biosynthetic pathway as a novel target for antifungal drugs against Candida species

ABSTRACT In recent decades, there has been an increase in the occurrence of fungal infections; yet, the arsenal of drugs available to fight invasive infections remains very limited. The development of new antifungal agents is hindered by the restricted number of molecular targets that can be exploit...

Full description

Bibliographic Details
Published in:mBio
Main Authors: Jana Nysten, Arne Peetermans, Dries Vaneynde, Stef Jacobs, Liesbeth Demuyser, Patrick Van Dijck
Format: Article
Language:English
Published: American Society for Microbiology 2024-11-01
Subjects:
Candida
antifungal
drug targets
transporter
riboflavin
vitamin B2
Online Access:https://journals.asm.org/doi/10.1128/mbio.02502-24

Internet

https://journals.asm.org/doi/10.1128/mbio.02502-24

Similar Items